Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
925
mi
from 91732
Lubbock, TX
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
925
mi
from 91732
Lubbock, TX
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
964
mi
from 91732
Seattle, WA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
1654
mi
from 91732
Madison, WI
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
7530
mi
from 91732
Liverpool,
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
7530
mi
from 91732
Liverpool,
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Children's Hospital of Alabama
1785
mi
from 91732
Birmingham, AL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Children's Hospital of Alabama
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Southern California Permanente Medical Group
15
mi
from 91732
Downey, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Southern California Permanente Medical Group
15
mi
from 91732
Downey, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
City of Hope
5
mi
from 91732
Duarte, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
City of Hope
5
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Loma Linda University Medical Center
43
mi
from 91732
Loma Linda, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Loma Linda University Medical Center
43
mi
from 91732
Loma Linda, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Children's Hospital and Research Center Oakland
352
mi
from 91732
Oakland, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Children's Hospital and Research Center Oakland
352
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Kaiser Permanente-Oakland
349
mi
from 91732
Oakland, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Kaiser Permanente-Oakland
349
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Children's Hospital of Orange County
21
mi
from 91732
Orange, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Children's Hospital of Orange County
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Lucile Packard Children's Hospital Stanford University
328
mi
from 91732
Palo Alto, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Lucile Packard Children's Hospital Stanford University
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of California Davis Cancer Center
363
mi
from 91732
Sacramento, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of California Davis Cancer Center
363
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of California San Francisco Medical Center-Parnassus
41
mi
from 91732
San Francisco, CA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of California San Francisco Medical Center-Parnassus
41
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Connecticut Children's Medical Center
2497
mi
from 91732
Hartford, CT
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Connecticut Children's Medical Center
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Alfred I. duPont Hospital for Children
2355
mi
from 91732
Wilmington, DE
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Alfred I. duPont Hospital for Children
2355
mi
from 91732
Wilmington, DE
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Lombardi Comprehensive Cancer Center at Georgetown University
2279
mi
from 91732
Washington,
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Lombardi Comprehensive Cancer Center at Georgetown University
2279
mi
from 91732
Washington,
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Golisano Children's Hospital of Southwest Florida
2202
mi
from 91732
Fort Myers, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Golisano Children's Hospital of Southwest Florida
2202
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of Florida
2104
mi
from 91732
Gainesville, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of Florida
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Memorial Healthcare System - Joe DiMaggio Children's Hospital
2317
mi
from 91732
Hollywood, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Memorial Healthcare System - Joe DiMaggio Children's Hospital
2317
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Nemours Children's Clinic-Jacksonville South
2130
mi
from 91732
Jacksonville, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Nemours Children's Clinic-Jacksonville South
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of Miami Miller School of Medicine-Sylvester Cancer Center
2321
mi
from 91732
Miami, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of Miami Miller School of Medicine-Sylvester Cancer Center
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Baptist Hospital of Miami
2320
mi
from 91732
Miami, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Baptist Hospital of Miami
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Florida Hospital Orlando
2184
mi
from 91732
Orlando, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Florida Hospital Orlando
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Nemours Children's Hospital
2184
mi
from 91732
Orlando, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Nemours Children's Hospital
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Nemours Children's Clinic - Pensacola
1809
mi
from 91732
Pensacola, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Nemours Children's Clinic - Pensacola
1809
mi
from 91732
Pensacola, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
All Children's Hospital
2130
mi
from 91732
Saint Petersburg, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
All Children's Hospital
2130
mi
from 91732
Saint Petersburg, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Saint Joseph Children's Hospital of Tampa
2136
mi
from 91732
Tampa, FL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Saint Joseph Children's Hospital of Tampa
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Children's Healthcare of Atlanta - Egleston
1922
mi
from 91732
Atlanta, GA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Children's Healthcare of Atlanta - Egleston
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Georgia Regents University Medical Center
2058
mi
from 91732
Augusta, GA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Georgia Regents University Medical Center
2058
mi
from 91732
Augusta, GA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Memorial University Medical Center
2130
mi
from 91732
Savannah, GA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Memorial University Medical Center
2130
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Lurie Children's Hospital- Chicago
1730
mi
from 91732
Chicago, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Lurie Children's Hospital- Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Univ of Illinois
1726
mi
from 91732
Chicago, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Univ of Illinois
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of Chicago
1730
mi
from 91732
Chicago, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Loyola University Medical Center
1719
mi
from 91732
Maywood, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Loyola University Medical Center
1719
mi
from 91732
Maywood, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Saint Jude Midwest Affiliate
1617
mi
from 91732
Peoria, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Saint Jude Midwest Affiliate
1617
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Southern Illinois University
1608
mi
from 91732
Springfield, IL
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Southern Illinois University
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Saint Vincent Hospital and Health Services
1793
mi
from 91732
Indianapolis, IN
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Saint Vincent Hospital and Health Services
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Blank Children's Hospital
1422
mi
from 91732
Des Moines, IA
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Blank Children's Hospital
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
University of Kentucky
1881
mi
from 91732
Lexington, KY
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
University of Kentucky
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated:  11/28/2016
Kosair Children's Hospital
1817
mi
from 91732
Louisville, KY
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Status: Enrolling
Updated: 11/28/2016
Kosair Children's Hospital
1817
mi
from 91732
Louisville, KY
Click here to add this to my saved trials